b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31351085</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>09</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>09</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1879-3150</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>169</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Nov</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Toxicon : official journal of the International Society on Toxinology</Title>\n                <ISOAbbreviation>Toxicon</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Botulinum toxin and occupational therapy for Writer\'s cramp.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>12-17</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0041-0101(19)30413-1</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.toxicon.2019.07.010</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Writer\'s cramp (WC) is a form of focal hand dystonia, for which focal botulinum neurotoxin (BoNT) injections are the current best therapy. Past studies have shown that some types of rehabilitative therapy can be useful. We hypothesized that BoNT together with a specific type of occupational therapy would be better than BoNT alone for treating WC patients comparing the effects with a patient-rated subjective scale.</AbstractText>\n                <AbstractText Label="METHODS" NlmCategory="METHODS">Twelve WC patients were randomized to two groups. Six received only BoNT therapy and 6 received BoNT &amp; occupational therapy. The occupational therapy involved specific exercises of finger movements in the direction opposite to the dystonic movements during writing. BoNT was injected by movement disorders neurologists in the affected muscles under electromyography-guidance. The primary outcome was the patient-rated subjective scale at 20 weeks. Secondary exploratory outcomes included the writer\'s cramp rating scale (WCRS), writer\'s cramp impairment scale (WCIS), the writer\'s cramp disability scale (WCDS), handgrip strength and kinetic parameters.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The patient-rated subjective scale scores at 20 weeks were not significantly different between the two groups. Significant objective improvement was noted in the BoNT &amp; occupational therapy group, as noted by the decrease (28%) in WCIS scores.</AbstractText>\n                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Improvement of the primary outcome measure, the patient-rated subjective scale, was not achieved. However, significant improvement was found in the BoNT &amp; occupational therapy group in a secondary measure of impairment. Our hypothesis-driven study results are likely limited by small sample size, and further large-scale studies of occupational therapy methods to improve the efficacy of BoNT seems worthwhile.</AbstractText>\n                <CopyrightInformation>Published by Elsevier Ltd.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Park</LastName>\n                    <ForeName>Jung E</ForeName>\n                    <Initials>JE</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, Dongguk University Ilsan Hospital, Goyang, Republic of Korea; Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Shamim</LastName>\n                    <ForeName>Ejaz A</ForeName>\n                    <Initials>EA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Panyakaew</LastName>\n                    <ForeName>Pattamon</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, Faculty of Medicine, Chulalongkorn Centre of Excellence on Parkinson Disease and Related Disorders, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mathew</LastName>\n                    <ForeName>Pawan</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Toro</LastName>\n                    <ForeName>Camilo</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sackett</LastName>\n                    <ForeName>Jonathan</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Karp</LastName>\n                    <ForeName>Barbara</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Combined Neuroscience Institutional Review Board, Office of the Clinical Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lungu</LastName>\n                    <ForeName>Codrin</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Clinical Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Rockville, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Alter</LastName>\n                    <ForeName>Katharine</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Functional and Applied Biomechanics Section, Rehabilitation Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wu</LastName>\n                    <ForeName>Tianxia</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Clinical Neuroscience Program, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ahmad</LastName>\n                    <ForeName>Omar F</ForeName>\n                    <Initials>OF</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA; Mount Carmel Neurology, Westerville, OH, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Villegas</LastName>\n                    <ForeName>Monica</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Auh</LastName>\n                    <ForeName>Sungyoung</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hallett</LastName>\n                    <ForeName>Mark</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. Electronic address: hallettm@ninds.nih.gov.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>ZIA NS003032-12</GrantID>\n                    <Agency>Intramural NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>24</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Toxicon</MedlineTA>\n            <NlmUniqueID>1307333</NlmUniqueID>\n            <ISSNLinking>0041-0101</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>EC 3.4.24.69</RegistryNumber>\n                <NameOfSubstance UI="D001905">Botulinum Toxins</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001905" MajorTopicYN="N">Botulinum Toxins</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D059026" MajorTopicYN="N">Diagnostic Self Evaluation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004421" MajorTopicYN="N">Dystonia</DescriptorName>\n                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020821" MajorTopicYN="N">Dystonic Disorders</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018737" MajorTopicYN="N">Hand Strength</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009788" MajorTopicYN="N">Occupational Therapy</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Botulinum</Keyword>\n            <Keyword MajorTopicYN="N">Dystonia</Keyword>\n            <Keyword MajorTopicYN="N">Focal</Keyword>\n            <Keyword MajorTopicYN="N">Hand</Keyword>\n            <Keyword MajorTopicYN="N">Occupational</Keyword>\n            <Keyword MajorTopicYN="N">Therapy</Keyword>\n            <Keyword MajorTopicYN="N">Toxin</Keyword>\n            <Keyword MajorTopicYN="N">Writer\'s cramp</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>20</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>23</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pmc-release">\n                <Year>2020</Year>\n                <Month>11</Month>\n                <Day>01</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>3</Month>\n                <Day>10</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31351085</ArticleId>\n            <ArticleId IdType="pii">S0041-0101(19)30413-1</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.toxicon.2019.07.010</ArticleId>\n            <ArticleId IdType="pmc">PMC6754272</ArticleId>\n            <ArticleId IdType="mid">NIHMS1537707</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Ann Neurol. 2002 May;51(5):593-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12112105</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mov Disord. 2005 Mar;20(3):335-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15486996</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Neurol. 2006 Feb;13 Suppl 1:55-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16417599</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hum Mov Sci. 2006 Oct;25(4-5):454-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16859794</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Parkinsonism Relat Disord. 2007 Apr;13(3):170-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17107822</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mov Disord. 2007 Jun 15;22(8):1102-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17230462</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mov Disord. 2008 Dec 15;23(16):2319-27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18816801</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Neurol Neurosurg. 2009 Feb;111(2):161-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18995953</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Toxicon. 2009 Oct;54(5):628-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19103214</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Phys Med Rehabil. 2009 May;90(5):867-75</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19406309</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mov Disord. 2011 Mar;26(4):750-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21506157</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Toxins (Basel). 2012 Nov 20;4(11):1404-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23202323</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Neurol. 2013 Nov;74(5):648-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23463596</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Parkinsonism Relat Disord. 2013 Jul;19(7):684-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23611688</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Neurophysiol. 2014 Apr;125(4):786-797</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24239452</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S66-S69</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28843401</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurol Neurosurg Psychiatry. 1996 Aug;61(2):172-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8708685</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurophysiol. 1998 Feb;79(2):1117-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9463469</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'